OSUR News and Press, OraSure Technologies Inc. From 05/10/22

OraSure Technologies press release (NASDAQ:OSUR): Q1 GAAP EPS of -$0.28. Revenue of $67.71M (+15.6% Y/Y). Shares -1%. For further details see: OraSure Technologies GAAP EPS of -$0.28, revenue of $67.71M

InteliSwab ® revenue of $22.1 million in Q1, up 50% sequentially with significant scaling in production Non-COVID molecular kits increase 42% year-over-year demonstrating continued strong growth Management to Host Analyst/Investor Call and Webcast Today ...

BETHLEHEM, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 first quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, May 10, 2022. May 10, 2...

The COVID-19 public health emergency that was set to expire on April 16 has been extended by 90 days into mid-July by Health and Human Services Secretary Xavier Becerra, Reuters reported. The emergency has required private health insurers to cover to cover the cost of COVID tests and vaccines...

Gainers: Sabre Corporation (SABR) +11%. Kura Sushi USA  (KRUS) +11%. WD-40 Company (WDFC) +10%. MediWound  (MDWD) +7%. Cognyte Software  (CGNT) +5%. Losers: OraSure Technologies (OSUR) -5%. Momentus  (MNTS) -5%. Icosavax  (ICVX) -5%. Berkeley ...

BETHLEHEM, Pa., April 07, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today its OMNIgene ® ·GUT Dx (OMD-200) microbiome collection device, has bee...

OraSure Technologies (NASDAQ:OSUR) Diversigen subsidiary has launched a new service to provide metatranscriptomic sequencing and analysis of gut microbiome samples. The metatranscriptomic services will generate a microbial community’s gene expression profile to inform customers about t...

BETHLEHEM, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its’ Diversigen subsidiary has launched a new service to provide metatra...

OraSure Technologies (NASDAQ:OSUR) has named Director Nancy Gagliano as interim CEO, effective Apr. 01, 2022. The Board's search for a permanent CEO is currently underway as President and CEO Stephen Tang leaves the company as of Mar. 31, 2022. Dr. Gagliano has been a member of the OraSure Bo...

Board Continues Search for Permanent CEO Evaluation of Strategic Alternatives Ongoing BETHLEHEM, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and micro...